Why Is Silence Therapeutics (SLN) Stock Up 125% Today?
Silence Therapeutics stock soared 125.69% on Monday following a $1.3 billion acquisition offer from Merck KGaA.
Silence Therapeutics Plc (SLN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Siren L.L.C. Raymond Debbane | 3,311,438 | $36,359,589 | +14% | 0.74% |
| 2. | Redmile Group Jeremy Green | 2,164,777 | $23,769,251 | 1.6% | |
| 3. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 1,346,731 | $14,787,106 | -38% | 0.49% |
| 4. | Citadel Investment Group Ken Griffin | 1,329,625 | $14,599,282 | +8% | 0% |
| 5. | Millennium Management Israel Englander | 909,279 | $9,983,883 | -16% | 0% |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 40,107 | $438,370 | 0.01% | |
| 2. | 11,207 | $122,493 | 0% | |
| 3. | 118 | $1,290 | 0% | |
| 4. | 48 | $525 | 0% | |
| 5. | 18 | $197 | 0% |
News See All
Silence Therapeutics (SLN) Gets 130% Premium Offer From Merck, Shares Surge Over 100%
Silence Therapeutics (NASDAQ:SLN) kicked off the trading week by more than doubling its share price, as investors snapped up its shares following Merck KGaA’s offer to acquire the company for a 130-...
Silence Therapeutics plc (SLN) Initiated at Overweight as Analyst Highlights siRNA Pipeline Potential
We recently compiled a list of the 10 Most Promising Cancer Stocks According to Wall Street Analysts. Silence Therapeutics plc (NASDAQ:SLN) is one of the most promising stocks on our list.
10 Most Promising Cancer Stocks According to Wall Street Analysts
In this article, we will be taking a look at the 10 Most Promising Cancer Stocks According to Wall Street Analysts.
10 Small Cap Stocks with Potential to Rise 1000 Percent
In this article, we look at 10 Small Cap Stocks with Potential to Rise 1000 Percent. Small-cap stocks have returned to the market’s risk conversation in 2026.
20 Takeover Rumors Hedge Funds Are Buying
This article will examine 20 takeover rumors that have prompted hedge funds to buy stocks. Hedge funds tend to pile up on a stock that gains or is expected to gain positive attention in a market.
Silence Therapeutics plc (NASDAQ:SLN) Q4 2024 Earnings Call Transcript
Silence Therapeutics plc (NASDAQ:SLN) Q4 2024 Earnings Call Transcript February 28, 2025 Gem Hopkins: Good morning and good afternoon, everyone. Thank you for joining us today.
10 Oversold Global Stocks To Buy Right Now
In this piece, we will take a look at ten oversold global stocks to buy now.
10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds
In this article, we will take a look at the 10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds.
Silence Therapeutics plc (NASDAQ:SLN) Q4 2023 Earnings Call Transcript
Silence Therapeutics plc (NASDAQ:SLN) Q4 2023 Earnings Call Transcript March 13, 2024 Silence Therapeutics plc misses on earnings expectations. Reported EPS is $-0.47 EPS, expectations were $-0.25.
Hedge Fund Resource Center